INDBInternet News Database 2.5 Updated 2 min ago · 292 sources Show or hide images Light or dark

Pfizer is tapping Blackstone for up to $1.5 billion to fund its weight-loss drug

1 source1 article First seen Updated United States Truth score 40

Save Like Comments Compare coverage
Image from Quartz

Summary

Blackstone would be eligible for milestone payments tied to U.S. approval of monthly berobenatide, while Pfizer keeps full control

Description from Quartz.

Who is covering this

  1. Quartz Leans left Factuality: High US
    Pfizer is tapping Blackstone for up to $1.5 billion to fund its weight-loss drug

    Blackstone would be eligible for milestone payments tied to U.S. approval of monthly berobenatide, while Pfizer keeps full control

Comments

Comments need JavaScript.